Suchergebnisse - "Arkam, Yazid"

PubPharm (11)

1

Dutcher bodies in a Waldenström Macroglobulinaemia patient

enthalten in: Annales de biologie clinique | 2024

von Checkouri, A. | Humbert, C. | Arkam, Y. | +1

2

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group

enthalten in: Haematologica | 2023

von Carras, S. | Torroja, A. | Emadali, A. | +40

3

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia : results from the French SPIRIT phase III randomised trial

enthalten in: Leukemia | 2021

von Guilhot, F. | Rigal-Huguet, F. | Guilhot, J. | +80

4

Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

enthalten in: American journal of hematology | 2020

von Sesques, P. | Ferrant, E. | Safar, V. | +33

5

Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center

enthalten in: American Journal of Hematology | 2020

von Sesques, P. | Ferrant, E. | Safar, V. | +33

6

Relapsed or refractory chronic lymphocytic leukemia retreated with rituximab in daily practice : final results of the PERLE study

enthalten in: Leukemia & lymphoma | 2019

von Chaoui, D. | Hacini, M. | Fitoussi, O. | +25

7

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma

enthalten in: Haematologica | 2019

von Gressin, R. | Daguindau, N. | Tempescul, A. | +38

8

Relapsed chronic lymphocytic leukemia retreated with rituximab : interim results of the PERLE study

enthalten in: Leukemia & lymphoma | 2017

von Chaoui, D. | Choquet, S. | Sanhes, L. | +15

9

Relapsed chronic lymphocytic leukemia retreated with rituximab: interim results of the PERLE study

enthalten in: Leukemia & lymphoma | 2017

von Chaoui, D. | Choquet, S. | Sanhes, L. | +15

10

Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct

enthalten in: Cytotherapy | 2009

von Pasquet, S. | Sovalat, H. | Hénon, P. | +8